Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SRR1 domain-containing protein (SRRD) is a human protein involved in the regulation of heme biosynthesis and regulation of circadian clock gene expression[2][3][8]. It belongs to the SRR1 family and is predicted to function in both the cytoplasm and nucleus[3][5][8]. While aliases reference hepatocellular carcinoma related to hemochromatosis, there is no direct evidence it serves as a cancer biomarker or therapeutic target. It is not classified as a receptor, enzyme, transporter, or transcription factor, and there are no known drugs targeting SRRD or established disease biomarker applications at this time[2][3][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SRR1 domain-containing protein (SRRD).